BIOMAT Database Logo BIOMAT Database Logo

The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe. 2006

Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
ORI Drug Development Center, Ordway Research Institute, Inc, 150 New Scotland Avenue, Albany, NY 12208, USA.

Pleconaril is a viral capsid inhibitor under evaluation for treatment of infections caused by rhinoviruses and enteroviruses. This study evaluated the effect of pleconaril on hepatic cytochrome P450 (CYP) 3A activity as assessed by intravenous (IV) midazolam. Healthy adults received oral pleconaril 400 mg 3 times daily for 16 doses. Single-dose, IV midazolam 0.025 mg/kg was administered before and during pleconaril administration. Midazolam and pleconaril plasma concentrations were assayed by LC/MS/MS. Bioequivalence was assessed by least squares geometric mean ratios (LS-GMR) with 90% confidence intervals (90% CIs) for the measured midazolam pharmacokinetic parameters. Sixteen subjects were enrolled, and 14 subjects completed the study. Pleconaril decreased midazolam AUC(0-infinity) 28% and increased systemic clearance 39%. LS-GMR (90% CI) were 0.718 (0.674-0.765) and 1.392 (1.307-1.483), respectively. Plasma pleconaril concentrations steadily increased over time. Observed changes in midazolam AUC(0-infinity) and systemic clearance suggest that oral pleconaril increased hepatic CYP3A activity in healthy adults.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008874 Midazolam A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. Dormicum,Midazolam Hydrochloride,Midazolam Maleate,Ro 21-3981,Versed,Hydrochloride, Midazolam,Maleate, Midazolam,Ro 21 3981,Ro 213981
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Effect of saquinavir-ritonavir on cytochrome P450 3A4 activity in healthy volunteers using midazolam as a probe.
October 2009, Pharmacotherapy,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
November 1999, Clinical pharmacology and therapeutics,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe.
August 2003, Clinical pharmacology and therapeutics,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice.
March 2007, Journal of clinical pharmacology,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Effect of Telavancin on the pharmacokinetics of the cytochrome P450 3A probe substrate midazolam: a randomized, double-blind, crossover study in healthy subjects.
February 2010, Pharmacotherapy,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Comparison of midazolam and simvastatin as cytochrome P450 3A probes.
April 2006, Clinical pharmacology and therapeutics,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Relationship between hepatic cytochrome P450 3A content and activity and the disposition of midazolam administered orally.
February 1998, Drug metabolism and disposition: the biological fate of chemicals,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Effect of borneol on cytochrome P450 3A enzyme and midazolam pharmacokinetics in rats.
September 2013, European journal of drug metabolism and pharmacokinetics,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.
October 1994, The Journal of pharmacology and experimental therapeutics,
Joseph D Ma, and Anne N Nafziger, and Gerry Rhodes, and Siyu Liu, and Anne M Gartung, and Joseph S Bertino
Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe.
March 2000, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!